Heregulin targets γ-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein

Molecular Cancer Research

Volumn 1, Issue 10, 2003, Pages 765-775

  Li, Yongqing ^a,b   Yu, Wei Hsuan ^a   Ren, Jian ^a   Chen, Wen ^a   Huang, Lei ^a   Kharbanda, Surender ^a,b   Loda, Massimo ^a   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ILEX Products Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN 1; NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; PLAKOGLOBIN; WNT PROTEIN;

ARTICLE; BREAST EPITHELIUM; CELL INTERACTION; COMPLEX FORMATION; DIMERIZATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; EFFECTOR CELL; HUMAN; HUMAN CELL; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; TARGET CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CELL ADHESION; CELL LINE, TUMOR; CELL NUCLEOLUS; CYTOSKELETAL PROTEINS; DESMOPLAKINS; EPIDERMAL GROWTH FACTOR; FEMALE; GAMMA CATENIN; HUMANS; NEOPLASM PROTEINS; NEUREGULIN-1; PHOSPHORYLATION; PROTEIN BINDING; RECEPTOR, ERBB-2;

EID: 0041828907     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Olayioye, M. A., Neve, R. M., Lane, H. A., and Hynes, N. E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J., 19: 3159-3167, 2000.
2. Carraway, K. L., III and Cantley, L. C. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell, 78: 5-8, 1994.
3. Riese D. J., II and Stern, D. F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays, 20: 41-48, 1998.
4. Wada, T., Qian, X. L., and Greene, M. I. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell, 61: 1339-1347, 1990.
5. Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., and Shoyab, M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. USA, 90: 1746-1750, 1993.
6. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., Yarden, Y. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol., 16: 5276-5287, 1996.
7. Graus-Porta, D., Beerli, R. R., Daly, J. M., and Hynes, N. E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J., 16: 1647-1655, 1997.
8. Olayioye, M. A., Graus-Porta, D., Beerli, R. R., Rohrer, J., Gay, B., and Hynes, N. E. ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol. Cell. Biol., 18: 5042-5051, 1998.
9. Ricci, A., Lanfrancone, L., Chiari, R., Belardo, G., Pertica, C., Natali, P. G., Pelicci, P. G., and Segatto, O. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase. Oncogene, 11: 1519-1529, 1995.
10. Zrihan-Licht, S., Deng, B., Yarden, Y., McShan, G., Keydar, I., and Avraham, H. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation. J. Biol. Chem., 273: 4065-4072, 1998.
11. Muthuswamy, S. K., Gilman, M., and Brugge, J. S. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol. Cell. Biol., 19: 6845-6857, 1999.
12. Janda, E., Litos, G., Grunert, S., Downward, J., and Beug, H. Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway. Oncogene, 21: 5148-5159, 2002.
13. Polakis, P. Wnt signaling and cancer. Genes Dev., 14: 1837-1851, 2000.
14. Lin, S. Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., Pestell, R. G., and Hung, M. C. β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. USA, 97: 4262-4266, 2000.
15. Kufe, D., Inghirami, G., Abe, M., Hayes, D., Justi-Wheeler, H., and Schlom, J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma, 3: 223-232, 1984.
16. Li, Y., Liu, D., Chen, D., Kharbanda, S., and Kufe, D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene, 22: 6107-6110, 2003.
17. Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J., and Burchell, J. A. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem., 263: 12820-12823, 1988.
18. Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E., and Kufe, D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl. Acad. Sci. USA, 85: 2320-2323, 1988.
19. Yamamoto, M., Bharti, A., Li, Y., and Kufe, D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J. Biol. Chem., 272: 12492-12494, 1997.
20. Li, Y., Bharti, A., Chen, D., Gong, J., and Kufe, D. Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol. Cell. Biol., 18: 7216-7224, 1998.
21. Li, Y., Kuwahara, H., Ren, J., Wen, G., and Kufe, D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin. J. Biol. Chem., 276: 6061-6064, 2001.
22. Li Y., Ren, J., Yu, W.-H., Li, G., Kuwahara, H., Yin, L., Carraway, K. L., and Kufe, D. The EGF receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and β-catenin. J. Biol. Chem., 276: 35239-35242, 2001.
23. Takeichi, M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem., 59: 237-252, 1990.
24. Li, Y., Chen, W., Ren, J., Yu, W., Li, Q., Yoshida, K., and Kufe, D. DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol. Ther., 2: 187-193, 2003.
25. Shimizu, H., Koyama, N., Asada, M., and Yoshimatsu, K. Aberrant expression of integrin and erbB subunits in breast cancer cell lines. Int. J. Oncol., 21: 1073-1079, 2002.
26. Ren, J., Li, Y., and Kufe, D. Protein kinase C δ regulates function of the DF3/MUC1 carcinoma antigen in β-catenin signaling. J. Biol. Chem., 277: 17616-17622, 2002.
27. Schroeder, J., Thompson, M., Gardner, M., and Gendler, S. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J. Biol. Chem., 276: 13057-13064, 2001.
28. Harari, D. and Yarden, Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene, 19: 6102-6114, 2000.
29. Hulsken, J., Birchmeier, W., and Behrens, J. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J. Cell Biol., 127: 2061-2069, 1994.
30. Keely, P. J., Westwick, J. K., Whitehead, I. P., Der, C. J., and Parise, L. V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature, 390: 632-636, 1997.
31. D'Souza, B. and Taylor-Papadimitriou, J. Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc. Natl. Acad. Sci. USA, 91: 7202-7206, 1994.
32. Shaw, P. J. and Jordan, E. G. The nucleolus. Annu. Rev. Cell Dev. Biol., 11: 93-121, 1995.
33. Politz, J. C., Yarovoi, S., Kilroy, S. M., Gowda, K., Zwieb, C., and Pederson, T. Signal recognition particle components in the nucleolus. Proc. Natl. Acad. Sci. USA, 97: 55-60, 2000.
34. Lange, T. S. and Gerbi, S. A. Transient nucleolar localization of U6 small nuclear RNA in Xenopus laevis oocytes. Mol. Biol. Cell, 11: 2419-2428, 2000.
35. Schneiter, R., Kadowaki, T., and Tartakoff, A. M. mRNA transport in yeast: time to reinvestigate the functions of the nucleolus. Mol. Biol. Cell, 6: 357-370, 1995.
36. Bertrand, E., Houser-Scott, F., Kendall, A., Singer, R. H., and Engelke, D. R. Nucleolar localization of early tRNA processing. Genes Dev., 12: 2463-2468, 1998.
37. Visintin, R. and Amon, A. The nucleolus: the magician's hat for cell cycle tricks. Curr. Opin. Cell Biol., 12: 372-377, 2000.
38. Zhang, Y. and Xiong, Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell, 3: 579-591, 1999.
39. Tao, W. and Levine, A. p19ARF stabilizes p53 by blocking nucleocytoplasmic shuttling of mdm2. Proc. Natl. Acad. Sci. USA, 96: 6937-6941, 1999.
40. Lohrum, M. A., Ashcroft, M., Kubbutat, M. H., and Vousden, K. H. Identification of a cryptic nucleolar-localization signal in MDM2. Nat. Cell Biol., 2: 179-181, 2000.
41. Kolligs, F. T., Kolligs, B., Hajra, K. M., Hu, G., Tani, M., Cho, K. R., and Fearon, E. R. γ-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev., 14: 1319-1331, 2000.
42. Fagotto, F., Gluck, U., and Gumbiner, B. M. Nuclear localization signalin-dependent and importin/karyopherin-independent nuclear import of β-catenin. Curr. Biol., 8: 181-190, 1998.
43. Prieve, M. G. and Waterman, M. L. Nuclear localization and formation of β-catenin-lymphoid enhancer factor I complexes are not sufficient for activation of gene expression. Mol. Cell. Biol., 19: 4503-4515, 1999.
44. Henderson, B. R. Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover. Nat. Cell Biol., 2: 653-660, 2000.
45. Neufeld, K. L., Zhang, F., Cullen, B. R., and White, R. L. APC-mediated downregulation of β-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep., 1: 519-523, 2000.
46. Dingwell, C. and Laskey, R. A. Nuclear targeting sequences - a consensus? Trends Biochem. Sci., 16: 478-482, 1991.
47. Makkerh, J. P., Dingwall, C., and Laskey, R. A. Comparative mutagenesis of nuclear localization signals reveals the importance of neutral and acidic amino acids. Curr. Biol., 6: 1025-1027, 1996.
48. Kharbanda, S., Saleem, A., Yuan, Z.-M., Kraeft, S., Weichselbaum, R., Chen, L. B., and Kufe, D. Nuclear signaling induced by ionizing radiation involves colocalization of the activated p56/p53lyn tyrosine kinase with p34cdc2. Cancer Res., 56: 3617-3621, 1996.